The nucleolar SUMO‐specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing-Reference-Cited by-同舟云学术

The nucleolar SUMO‐specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing

Published:2008-02-08 Issue:3 Volume:9 Page:273-279
ISSN:1469-221X
Container-title:EMBO reports
language:en
Short-container-title:EMBO Rep

Author:

Haindl Markus¹,Harasim Thomas²,Eick Dirk²,Muller Stefan¹

Affiliation:

1. Department of Molecular Cell Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18 D‐82152 Martinsried Germany

2. Institute of Clinical Molecular Biology and Center for Integrated Protein Science, CIPSM, Helmholtz Zentrum München, Marchioninistrasse 25 D‐81377 München Munich Germany

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/embor.2008.3

Reference31 articles.

1. Distinct In Vivo Dynamics of Vertebrate SUMO Paralogues

2. MDM2-ARF complex regulates p53 sumoylation

3. The DEAD-box RNA helicase SrmB is involved in the assembly of 50S ribosomal subunits in Escherichia coli

4. The SUMO-Specific Protease SENP5 Is Required for Cell Division

5. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SUMOylation regulation of ribosome biogenesis: Emerging roles for USP36;Frontiers in RNA Research;2024-04-03

2. SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases;BioFactors;2024-03-29

3. Porcine circovirus type 2 infection promotes the SUMOylation of nucleophosmin-1 to facilitate the viral circular single-stranded DNA replication;PLOS Pathogens;2024-02-23

4. Hypoxia-driven deSUMOylation of EXOSC10 promotes adaptive changes in the transcriptome profile;Cellular and Molecular Life Sciences;2024-01-27

5. Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy;Molecular Medicine;2024-01-20